Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
Braze, Inc. (NASDAQ:BRZE) shares surged 14.3% in pre-market trading after reporting better-than-expected first-quarter earnings. Other notable pre-market movers include Venus Concept Inc. (NASDAQ:VERO), Versus Systems Inc. (NASDAQ:VS), GameStop Corp. (NYSE:GME), and Geron Corporation (NASDAQ:GERN). On the losing side, Biomea Fusion, Inc. (NASDAQ:BMEA) shares plummeted 59.2% after an FDA clinical hold notice.

June 07, 2024 | 9:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Braze, Inc. shares rose 14.3% in pre-market trading after reporting better-than-expected first-quarter earnings, with revenue and adjusted loss per share beating estimates.
Braze's better-than-expected earnings report, with both revenue and adjusted loss per share beating estimates, is a strong positive signal for investors, leading to a significant pre-market price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Geron Corporation shares climbed 14.3% in pre-market trading after FDA approval of RYTELO™ for treating lower-risk MDS with transfusion-dependent anemia.
FDA approval of RYTELO™ is a significant milestone for Geron Corporation, leading to a notable pre-market price increase.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
GameStop Corp. shares rose 35.3% in pre-market trading after a 47% increase on Thursday.
GameStop's significant pre-market price increase follows a substantial gain on Thursday, indicating strong investor interest and positive sentiment.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Venus Concept Inc. shares surged 135.8% in pre-market trading after regaining compliance with Nasdaq’s minimum equity requirement.
Regaining compliance with Nasdaq’s minimum equity requirement is a significant positive development for Venus Concept, leading to a substantial pre-market price increase.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Versus Systems Inc. shares gained 89.1% in pre-market trading following a 27% increase on Thursday.
The significant pre-market price increase follows a strong performance on Thursday, indicating continued positive momentum for Versus Systems.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Biomea Fusion, Inc. shares declined 59.2% in pre-market trading after receiving an FDA clinical hold notice for its trials of BMF-219.
The FDA clinical hold notice for BMF-219 trials is a significant negative development for Biomea Fusion, leading to a sharp decline in pre-market trading.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90